Latest thinking.

Explore our latest insights and perspectives in these life science resources, news articles, and events.

Topic

Content Type

Real-World Evaluation of Treatment Patterns and Reso...

Putnam PHMR’s client needed a detailed description of multiple myeloma treatment patterns and resource utilization in Japanese patients...

Global commercialization blueprint for emerging biotech

An emerging biotech sought Putnam’s guidance to design and execute the global commercialization of their asset for a rare oncology indication.

Designing a lean launch strategy and GTM model

A global, top-10 pharma client sought Putnam’s guidance on developing a lean launch strategy for a novel cell therapy in oncology.

Dynamic disease modeling in NSCLC

The client with a focus on developing pipeline asset for KRAS G12C segment sought granular insights for competitive edge in treatment sequencing.

Local medical launch readiness plans

Putnam PHMAR helped the client to support development of local medical launch readiness plans for a new vaccine.

Indirect treatment comparison (ITC) to generate comp...

A company was approaching the European market with evidence from a placebo-controlled RCT, but with several established competitors...

Go/no-go decision for early asset

With several other in-class competitors, a client sought Putnam’s guidance on a go/no-go development decision for a first-generation targeted...

Portfolio prioritization & optimization

A clinical-stage biopharmaceutical company sought to develop an optimized portfolio strategy. It sought Putnam’s guidance to prioritize asset-level...

Global vaccine forecasting

Stay ahead in vaccine market strategy as competitor's halt forces Putnam's client to adapt global forecasts for dynamic launch scenarios.

HTA evidence generation and preparedness for a novel...

Our client needed successful HTA evidence packages and submissions to achieve reimbursement across Europe for an innovative oncology treatment...

AI algorithm landscape assessment

Read how our client aims to locate organizations advancing AI algorithms for rare disease detection.

Early oncology portfolio execution roadmap

We worked with our client to develop a forward-looking early development program evaluation tool that identifies key inflection points...

Load 12 more of 17

Get in touch.

Looking to get in touch with an expert or team member?

Tell us how we can help.

Get in touch

Centers of Excellence